Search

Marsha M. Tsay

Examiner (ID: 332, Phone: (571)272-2938 , Office: P/1656 )

Most Active Art Unit
1656
Art Unit(s)
1656, 1653
Total Applications
1124
Issued Applications
471
Pending Applications
130
Abandoned Applications
543

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7777285 [patent_doc_number] => 20120040385 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'COAGULOGEN RAW MATERIAL, PROCESS FOR PRODUCING THE SAME, AND METHOD AND APPARATUS FOR MEASURING PHYSIOLOGICALLY ACTIVE SUBSTANCE OF BIOLOGICAL ORIGIN USING THE SAME' [patent_app_type] => utility [patent_app_number] => 13/202285 [patent_app_country] => US [patent_app_date] => 2010-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11076 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20120040385.pdf [firstpage_image] =>[orig_patent_app_number] => 13202285 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/202285
Coagulogen raw material, process for producing the same, and method and apparatus for measuring physiologically active substance of biological origin using the same Feb 18, 2010 Issued
Array ( [id] => 7581105 [patent_doc_number] => 20110294988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'Purification Process' [patent_app_type] => utility [patent_app_number] => 13/148260 [patent_app_country] => US [patent_app_date] => 2010-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16054 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294988.pdf [firstpage_image] =>[orig_patent_app_number] => 13148260 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/148260
Purification Process Feb 4, 2010 Abandoned
Array ( [id] => 8199297 [patent_doc_number] => 20120122791 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'SUBSTRATE FOR CARTILAGE CULTIVATION USING ARTIFICIAL COLLAGEN, AND METHOD FOR CARTILAGE REGENERATION TREATMENT USING THE SUBSTRATE' [patent_app_type] => utility [patent_app_number] => 13/318312 [patent_app_country] => US [patent_app_date] => 2010-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10858 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20120122791.pdf [firstpage_image] =>[orig_patent_app_number] => 13318312 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/318312
SUBSTRATE FOR CARTILAGE CULTIVATION USING ARTIFICIAL COLLAGEN, AND METHOD FOR CARTILAGE REGENERATION TREATMENT USING THE SUBSTRATE Feb 1, 2010 Abandoned
Array ( [id] => 10547392 [patent_doc_number] => 09271992 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-01 [patent_title] => 'Method for alleviating pain using sphingosine-1-phosphate and related compounds, and assays for identifying such compounds' [patent_app_type] => utility [patent_app_number] => 12/696250 [patent_app_country] => US [patent_app_date] => 2010-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 173 [patent_figures_cnt] => 54 [patent_no_of_words] => 16598 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12696250 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/696250
Method for alleviating pain using sphingosine-1-phosphate and related compounds, and assays for identifying such compounds Jan 28, 2010 Issued
Array ( [id] => 6510468 [patent_doc_number] => 20100210745 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'Molecular Healing of Polymeric Materials, Coatings, Plastics, Elastomers, Composites, Laminates, Adhesives, and Sealants by Active Enzymes' [patent_app_type] => utility [patent_app_number] => 12/696651 [patent_app_country] => US [patent_app_date] => 2010-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 343081 [patent_no_of_claims] => 108 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20100210745.pdf [firstpage_image] =>[orig_patent_app_number] => 12696651 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/696651
Molecular Healing of Polymeric Materials, Coatings, Plastics, Elastomers, Composites, Laminates, Adhesives, and Sealants by Active Enzymes Jan 28, 2010 Abandoned
Array ( [id] => 7587522 [patent_doc_number] => 20110282032 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'PROCESS FOR HIGHLY SELECTIVE PURIFICATION OF TWO PLASMA PROTEINS: VON WILLEBRAND FACTOR (VWF) AND FIBRONECTIN (FN)' [patent_app_type] => utility [patent_app_number] => 13/145038 [patent_app_country] => US [patent_app_date] => 2010-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2923 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0282/20110282032.pdf [firstpage_image] =>[orig_patent_app_number] => 13145038 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/145038
Process for highly selective purification of two plasma proteins: von willebrand factor (vWF) and fibronectin (Fn) Jan 18, 2010 Issued
Array ( [id] => 7567005 [patent_doc_number] => 20110287068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-24 [patent_title] => 'FIBRIN AND FIBRINOGEN MATRICES AND USES OF SAME' [patent_app_type] => utility [patent_app_number] => 13/143196 [patent_app_country] => US [patent_app_date] => 2009-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15871 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20110287068.pdf [firstpage_image] =>[orig_patent_app_number] => 13143196 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/143196
FIBRIN AND FIBRINOGEN MATRICES AND USES OF SAME Dec 30, 2009 Abandoned
Array ( [id] => 7695945 [patent_doc_number] => 20110230645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'PURIFICATION OF FACTOR V' [patent_app_type] => utility [patent_app_number] => 13/131001 [patent_app_country] => US [patent_app_date] => 2009-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6420 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0230/20110230645.pdf [firstpage_image] =>[orig_patent_app_number] => 13131001 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/131001
PURIFICATION OF FACTOR V Dec 14, 2009 Abandoned
Array ( [id] => 6431208 [patent_doc_number] => 20100152115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'DETECTION OF PHYSIOLOGICALLY ACCEPTABLE POLYMER MOLECULES USING NEAR INFRARED SPECTROSCOPY' [patent_app_type] => utility [patent_app_number] => 12/636382 [patent_app_country] => US [patent_app_date] => 2009-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9344 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20100152115.pdf [firstpage_image] =>[orig_patent_app_number] => 12636382 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/636382
DETECTION OF PHYSIOLOGICALLY ACCEPTABLE POLYMER MOLECULES USING NEAR INFRARED SPECTROSCOPY Dec 10, 2009 Abandoned
Array ( [id] => 6413540 [patent_doc_number] => 20100166834 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'PREPARATIONS BASED ON FIBRINOGEN AND SULFATED POLYSACCHARIDES' [patent_app_type] => utility [patent_app_number] => 12/636620 [patent_app_country] => US [patent_app_date] => 2009-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9281 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20100166834.pdf [firstpage_image] =>[orig_patent_app_number] => 12636620 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/636620
Preparations based on fibrinogen and sulfated polysaccharides Dec 10, 2009 Issued
Array ( [id] => 7567455 [patent_doc_number] => 20110287518 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-24 [patent_title] => 'Polypeptide Purification' [patent_app_type] => utility [patent_app_number] => 13/131757 [patent_app_country] => US [patent_app_date] => 2009-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12887 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20110287518.pdf [firstpage_image] =>[orig_patent_app_number] => 13131757 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/131757
Polypeptide Purification Nov 30, 2009 Abandoned
Array ( [id] => 5929821 [patent_doc_number] => 20110039780 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => 'PLATELET GLYCOPROTEIN IB ALPHA VARIANT FUSION POLYPEPTIDES AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/621887 [patent_app_country] => US [patent_app_date] => 2009-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10384 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20110039780.pdf [firstpage_image] =>[orig_patent_app_number] => 12621887 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/621887
PLATELET GLYCOPROTEIN IB ALPHA VARIANT FUSION POLYPEPTIDES AND METHODS OF USE THEREOF Nov 18, 2009 Abandoned
Array ( [id] => 11197304 [patent_doc_number] => 09427499 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-30 [patent_title] => 'Surface modification of silk fibroin matrices with poly(ethylene glycol) useful as anti-adhesion barriers and anti-thrombotic materials' [patent_app_type] => utility [patent_app_number] => 13/129738 [patent_app_country] => US [patent_app_date] => 2009-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 14 [patent_no_of_words] => 11190 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13129738 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/129738
Surface modification of silk fibroin matrices with poly(ethylene glycol) useful as anti-adhesion barriers and anti-thrombotic materials Nov 16, 2009 Issued
Array ( [id] => 5976825 [patent_doc_number] => 20110070625 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-24 [patent_title] => 'NOVEL FLUORESCENT PROTEINS AND METHODS FOR USING SAME' [patent_app_type] => utility [patent_app_number] => 12/619488 [patent_app_country] => US [patent_app_date] => 2009-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14836 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20110070625.pdf [firstpage_image] =>[orig_patent_app_number] => 12619488 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/619488
Fluorescent proteins and methods for using same Nov 15, 2009 Issued
Array ( [id] => 6543115 [patent_doc_number] => 20100125052 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-20 [patent_title] => 'ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME IN COMBINATION WITH BLOOD COAGULATING AGENTS' [patent_app_type] => utility [patent_app_number] => 12/616735 [patent_app_country] => US [patent_app_date] => 2009-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 34174 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20100125052.pdf [firstpage_image] =>[orig_patent_app_number] => 12616735 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/616735
Antidotes for factor Xa inhibitors and methods of using the same in combination with blood coagulating agents Nov 10, 2009 Issued
Array ( [id] => 6423820 [patent_doc_number] => 20100168018 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'FACTOR VIII FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 12/614090 [patent_app_country] => US [patent_app_date] => 2009-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16589 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20100168018.pdf [firstpage_image] =>[orig_patent_app_number] => 12614090 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/614090
FACTOR VIII FORMULATIONS Nov 5, 2009 Abandoned
Array ( [id] => 7686048 [patent_doc_number] => 20100120093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'Method of Producing Serum-Free Insulin-Free Factor VII' [patent_app_type] => utility [patent_app_number] => 12/612752 [patent_app_country] => US [patent_app_date] => 2009-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14157 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20100120093.pdf [firstpage_image] =>[orig_patent_app_number] => 12612752 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/612752
Method of Producing Serum-Free Insulin-Free Factor VII Nov 4, 2009 Abandoned
Array ( [id] => 6322950 [patent_doc_number] => 20100113743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'GLYCOPEGYLATED FACTOR VII AND FACTOR VIIA' [patent_app_type] => utility [patent_app_number] => 12/605041 [patent_app_country] => US [patent_app_date] => 2009-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 66 [patent_figures_cnt] => 66 [patent_no_of_words] => 44429 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12605041 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/605041
GLYCOPEGYLATED FACTOR VII AND FACTOR VIIA Oct 22, 2009 Abandoned
Array ( [id] => 7743305 [patent_doc_number] => 20120021484 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'Recombinant FcRn and Variants Thereof for Purification of Fc-Containing Fusion Proteins' [patent_app_type] => utility [patent_app_number] => 13/125795 [patent_app_country] => US [patent_app_date] => 2009-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 13338 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20120021484.pdf [firstpage_image] =>[orig_patent_app_number] => 13125795 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/125795
Recombinant FcRn and Variants Thereof for Purification of Fc-Containing Fusion Proteins Oct 20, 2009 Abandoned
Array ( [id] => 6250379 [patent_doc_number] => 20100137816 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'Injection of fibrin sealant including an anesthetic in spinal applications' [patent_app_type] => utility [patent_app_number] => 12/587309 [patent_app_country] => US [patent_app_date] => 2009-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5887 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20100137816.pdf [firstpage_image] =>[orig_patent_app_number] => 12587309 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/587309
Injection of fibrin sealant including an anesthetic in spinal applications Oct 4, 2009 Issued
Menu